by Kenjiro Lolling | Jan 30, 2025 | News
Yesterday, NecstGen, Leiden University Medical Center (LUMC), NTrans Biotechnologies B.V., and Divvly launched the IPCEI-P-SMaRT project, an initiative under IPCEI Med4Cure. The project is focused on improving gene editing and gene therapy manufacturing, strengthening...
by Kenjiro Lolling | Jan 30, 2025 | News
Leiden, January 30th — The Stichting LBSP (Leiden Bio Science Park Foundation) is proud to announce the partnership with 360Pharma, supported by the Career Lab initiative, to launch an advanced talent portal on the 16th March 2025. This platform is set to...
by Kenjiro Lolling | Jan 28, 2025 | News
Improving Drug Discovery with Natural Flow Conditions OrganoPlate UF enables physiologically relevant tissue models by using unidirectional, gravity-driven flow, removing the need for external pumps. This approach simplifies operation while maintaining biological...
by Kenjiro Lolling | Jan 22, 2025 | News
Advancing Multi-Species In Vitro Assays During phase 2, Toxys will continue to develop and refine multi-species (human, rat, and rabbit) in vitro assays to predict in vivo teratogenicity. The team will qualify these assays using positive and negative reference...
by Kenjiro Lolling | Jan 21, 2025 | News
Pharming Group has nominated Fabrice Chouraqui as the successor to CEO Sijmen de Vries. His appointment will be subject to approval at an Extraordinary General Meeting of Shareholders (EGM). Upon his appointment, Chouraqui will join the Board of Directors, while De...